These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8977222)

  • 61. Receptor-directed therapy of T-cell leukemias and lymphomas.
    Morris JC; Waldmann TA; Janik JE
    J Immunotoxicol; 2008 Apr; 5(2):235-48. PubMed ID: 18569395
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Retrovirally induced CTL degranulation mediated by IL-15 expression and infection of mononuclear phagocytes in patients with HTLV-I-associated neurologic disease.
    Enose-Akahata Y; Oh U; Grant C; Jacobson S
    Blood; 2008 Sep; 112(6):2400-10. PubMed ID: 18509087
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet's disease.
    Buggage RR; Levy-Clarke G; Sen HN; Ursea R; Srivastava SK; Suhler EB; Altemare C; Velez G; Ragheb J; Chan CC; Nussenblatt RB; Bamji AT; Sran P; Waldmann T; Thompson DJ
    Ocul Immunol Inflamm; 2007; 15(2):63-70. PubMed ID: 17558830
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Anti-Tac (daclizumab, Zenapax) in the treatment of leukemia, autoimmune diseases, and in the prevention of allograft rejection: a 25-year personal odyssey.
    Waldmann TA
    J Clin Immunol; 2007 Jan; 27(1):1-18. PubMed ID: 17216565
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Preclinical and phase I clinical trial of blockade of IL-15 using Mikbeta1 monoclonal antibody in T cell large granular lymphocyte leukemia.
    Morris JC; Janik JE; White JD; Fleisher TA; Brown M; Tsudo M; Goldman CK; Bryant B; Petrus M; Top L; Lee CC; Gao W; Waldmann TA
    Proc Natl Acad Sci U S A; 2006 Jan; 103(2):401-6. PubMed ID: 16387851
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cytokines in posterior uveitis: an update.
    Singh VK; Rai G
    Immunol Res; 2001; 23(1):59-74. PubMed ID: 11417860
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The pathogenesis and clinical presentation of macular edema in inflammatory diseases.
    Guex-Crosier Y
    Doc Ophthalmol; 1999; 97(3-4):297-309. PubMed ID: 10896343
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Daclizumab: a review of its use in the prevention of acute rejection in renal transplant recipients.
    Wiseman LR; Faulds D
    Drugs; 1999 Dec; 58(6):1029-42. PubMed ID: 10651389
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunomodulation of autoimmune responses with monoclonal antibodies and immunoadhesins: treatment of ocular inflammatory disease in the next millennium.
    Dick AD; Isaacs JD
    Br J Ophthalmol; 1999 Nov; 83(11):1230-4. PubMed ID: 10535846
    [No Abstract]   [Full Text] [Related]  

  • 70. Immune mechanisms in uveitis.
    Caspi RR
    Springer Semin Immunopathol; 1999; 21(2):113-24. PubMed ID: 10457585
    [No Abstract]   [Full Text] [Related]  

  • 71. Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial.
    Nussenblatt RB; Fortin E; Schiffman R; Rizzo L; Smith J; Van Veldhuisen P; Sran P; Yaffe A; Goldman CK; Waldmann TA; Whitcup SM
    Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7462-6. PubMed ID: 10377437
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Treatment of uveitis with recombinant human interleukin-13.
    Roberge FG; de Smet MD; Benichou J; Kriete MF; Raber J; Hakimi J
    Br J Ophthalmol; 1998 Oct; 82(10):1195-8. PubMed ID: 9924310
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Humanized Mik beta 1, a humanized antibody to the IL-2 receptor beta-chain that acts synergistically with humanized anti-TAC.
    Hakimi J; Ha VC; Lin P; Campbell E; Gately MK; Tsudo M; Payne PW; Waldmann TA; Grant AJ; Tsien WH
    J Immunol; 1993 Jul; 151(2):1075-85. PubMed ID: 8335891
    [TBL] [Abstract][Full Text] [Related]  

  • 74. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
    Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Anti-cytokines and anti-cytokine receptors].
    Dantal J; Giral M; Soulillou JP
    Rev Prat; 1993 Mar; 43(5):586-9. PubMed ID: 8341928
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Humanized antibodies against the alpha-chain of the IL-2 receptor and against the beta-chain shared by the IL-2 and IL-15 receptors in a monkey uveitis model of autoimmune diseases.
    Guex-Crosier Y; Raber J; Chan CC; Kriete MS; Benichou J; Pilson RS; Kerwin JA; Waldmann TA; Hakimi J; Roberge FG
    J Immunol; 1997 Jan; 158(1):452-8. PubMed ID: 8977222
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Bispecific humanized anti-IL-2 receptor alpha beta antibodies inhibitory for both IL-2- and IL-15-mediated proliferation.
    Pilson RS; Levin W; Desai B; Reik LM; Lin P; Korkmaz-Duffy E; Campbell E; Tso JY; Kerwin JA; Hakimi J
    J Immunol; 1997 Aug; 159(3):1543-56. PubMed ID: 9233654
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.